Simultaneous Blockade of CD209 and CD209L by Monoclonal Antibody Does Not Provide Sufficient Protection Against Multiple Viral Infections In Vivo
Immunology · 2025
DOI: 10.1111/imm.13889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Yanyun Du und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory for Human Disease Gene Study of Sichuan Province, Department of Laboratory Medicine, Sichuan Provincial People's Hospital, Univers…. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Antibodies, Monoclonal, Receptors, Cell Surface, Lectins, C-Type. Die Arbeit nennt 62 Literaturangaben. Gefördert von: The National Science Foundation for Distinguished Young Scholars of China, National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Many virus species, including Ebola virus, Marburg virus, SARS‐CoV‐2, dengue virus (DENV) and Zika virus (ZIKV), exploit CD209 and CD209L as alternative or attachment receptors for viral cis‐ or trans‐infection. Thus, CD209 and CD209L may be critical targets for the development of therapeutic monoclonal blocking antibody drugs to disrupt the infection process caused by multiple viruses. Here, we produced a human chimeric monoclonal blocking antibody that simultaneously blocks CD209 and CD209L, namely 7‐H7‐B1. We show that 7‐H7‐B1 effectively blocks multiple pseudotyped or live viral infections in vitro, including SARS‐CoV, SARS‐CoV‐2, Ebola virus, Marburg virus, ZIKV and DENV infections. However, the 7‐H7‐B1 mAb does not provide favourable protection against Zaire Ebola virus or ZIKV infection in h CD209 knock‐in mice in vivo. Thus, our findings indicate that although CD209 and CD209L are critical for multiple viral infections in vitro, they may play only a partial role in viral infections in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory for Human Disease Gene Study of Sichuan Province, Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Sichuan Medical Laboratory Clinical Medical Research Center, Sichuan Provincial People's Hospital, Chengdu, China.
- Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
- State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, P.R. China.
- University of Chinese Academy of Sciences, Beijing, P.R. China.
ORCID-Profile: Chenhui Wang
Förderung
- The National Science Foundation for Distinguished Young Scholars of China
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- the Postdoctoral Foundation of Sichuan Provincial People's Hospital
- Postdoctoral Foundation of Sichuan Province
- Postdoctoral Foundation of China
- Sichuan Postdoctoral Innovation Plan
- The original exploration program of the National Natural Science Foundation of China
Zitieren
APA
Du, Y., Gao, J., He, M., Yi, M., Wu, J., Feng, L., Zeng, B., Li, Y., He, R., Wang, Y., Qin, C. F., Cui, Z., & Wang, C. (2025). Simultaneous Blockade of CD209 and CD209L by Monoclonal Antibody Does Not Provide Sufficient Protection Against Multiple Viral Infections In Vivo. Immunology. https://doi.org/10.1111/imm.13889
Vancouver
Du Y, Gao J, He M, Yi M, Wu J, Feng L, et al. Simultaneous Blockade of CD209 and CD209L by Monoclonal Antibody Does Not Provide Sufficient Protection Against Multiple Viral Infections In Vivo. Immunology. 2025. doi:10.1111/imm.13889
BibTeX
@article{Du2025,
author = {Du, Yanyun and Gao, Jiawang and He, Mengjiao and Yi, Ming and Wu, Jiaqi and Feng, Lingyun and Zeng, Bo and Li, Yangyang and He, Ruirui and Wang, Yuan and Qin, Cheng-Feng and Cui, Zongqiang and Wang, Chenhui},
title = {Simultaneous Blockade of CD209 and CD209L by Monoclonal Antibody Does Not Provide Sufficient Protection Against Multiple Viral Infections In Vivo},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.13889}
}
EUVIMED